Benjamin Enerson

General Counsel at THESEUS PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Health Services

Profile

Benjamin Enerson is currently working as Vice President-Legal Affairs at Theseus Pharmaceuticals, Inc. Prior to this, he worked as General Counsel at Finch Therapeutics Group, Inc. and Tremeau Pharmaceuticals, Inc. He completed his undergraduate degree from Vanderbilt University and his graduate degree from Cornell Law School in 2004.

Benjamin Enerson active positions

Companies	Position	Start
THESEUS PHARMACEUTICALS, INC.	General Counsel	-

All active positions of Benjamin Enerson

Former positions of Benjamin Enerson

Companies	Position	End
FINCH THERAPEUTICS GROUP, INC.	General Counsel	-
Tremeau Pharmaceuticals, Inc. Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA.	General Counsel	-

See the detail of Benjamin Enerson's experience

Training of Benjamin Enerson

Cornell Law School	Graduate Degree
Vanderbilt University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Benjamin Enerson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
FINCH THERAPEUTICS GROUP, INC.	Health Services

Private companies	2
Theseus Pharmaceuticals, Inc. Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA.	Health Technology
Tremeau Pharmaceuticals, Inc. Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA.	Health Technology